AMJCtv interviews let you catch up with experts on what's new and important about the changes in healthcare. Where else can a few minutes of your time give you insights from key decision makers - from the clinician, to the health plan leader, to the regulator? AJMCtv interviews give you the close-ups you might not get even if you make it to the conference. When every minute in your day matters, AJMCtv interviews keep you informed.
Comparative effectiveness research (CER) collaborative tools can benefit pharmaceutical companies in a variety of ways.
It is well known that oncology care pathways are the tools that practices can utilize to care for its patients. Ira Klein, MD, MBA, FACP, chief medical officer, National Accounts Clinical Sales & Strategy, Aetna, suggests that Aetna’s only involvement in creating these pathways should be in helping these practices develop “reasonable care pathways.”
Michael Bousselot, policy advisor, Office of the Governor for the state of Iowa, believes that the Healthiest State Initiative effectively improves the populations’ health and wellbeing because it is privately led and publicly endorsed.
Laurel Pickering, MPH, president & CEO of the Northeast Business Group on Health, explains that employers are transitioning employees into consumers with the help of “transparency tools” centered around price and quality.
While electronic health records (EHRs) enable Geisinger Health System to integrate and partner with new systems, Michael Evans, RPh, director, ambulatory clinical pharmacy programs, Geisinger Health System, suggests that the organization’s pre-established managed care process is what sets Geisinger apart in the integrated delivery network/accountable care organization (IDN/ACO) marketplace.
Ed Cohen, PharmD, FAPhA, senior manager, product development, corporate innovations at Walgreens, explains that patient education and medication adherence are 2 major gaps in transitions of care.
Anthony Rothschild, MD, a professor at the Irving S. and Betty Brudnick Endowed Chair of Psychiatry, University of Massachusetts Medical School, says that many primary care physicians feel more comfortable prescribing newer anti-depressant drugs with fewer side effects.
Paul N. Van de Water, senior fellow, Center on Budget and Policy Priorities, suggests that controlling healthcare costs and spending is a complicated process — one in which no right answer exists.